JANX Janux Therapeutics, Inc.
Nasdaq · SEC CIK 1817713 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $1.06M 11 sales by 7 insiders
- Filings on record
- 128 since 2021-09-09, latest 2026-07-31 20:00
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Meyer Andrew Hollman | Chief Business Off | — | $736.7K |
| Campbell David Alan | Pres, CEO, Dir | — | $110.8K |
| Doyle Janeen Noel | Chief Corp, Bus. Dev. Ofcr | — | $56.9K |
| Dobek Maria | VP, Accounting | — | $49.0K |
| McIver Zachariah | Chief Medical Off | — | $37.3K |
| DiRaimondo Thomas | CSO | — | $34.4K |
| Winter Charles M. | Chief Technical Off | — | $33.0K |
| Go William | Chief Medical Off | — | — |
| Simson Jake | Dir | — | — |
| Hernday Natasha | Dir | — | — |
Transactions 113
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-31 20:00 | 2026-07-31 | JANX | Campbell David Alan | Pres, CEO, Dir | G - Gift | $0.00 | -123.8K | 264.7K | -32% | $0 | |
| D | 2026-07-10 20:00 | 2026-07-08 | JANX | Campbell David Alan | Pres, CEO, Dir | M - OptEx | $4.21 | +7,000 | 388.6K | +2% | +$29.5K |
| DI | 2026-06-12 20:30 | 2026-06-11 | JANX | RA CAPITAL MANAGEMENT, L.P. | Dir, 10% | A - Grant | $0.00 | +5,500 | 11.8K | +88% | $0 |
| D | 2026-06-12 20:00 | 2026-06-11 | JANX | Simson Jake | Dir | A - Grant | $0.00 | +5,500 | 11.8K | +88% | $0 |
| D | 2026-06-12 20:00 | 2026-06-11 | JANX | Kung Winston | Dir | A - Grant | $0.00 | +5,500 | 11.8K | +88% | $0 |
| D | 2026-06-12 20:00 | 2026-06-11 | JANX | Hernday Natasha | Dir | A - Grant | $0.00 | +5,500 | 15.5K | +55% | $0 |
| D | 2026-06-12 20:00 | 2026-06-11 | JANX | DOBMEIER ERIC | Dir | A - Grant | $0.00 | +5,500 | 15.5K | +55% | $0 |
| D | 2026-06-12 20:00 | 2026-06-11 | JANX | CAPPS VICKIE L | Dir | A - Grant | $0.00 | +5,500 | 79.6K | +7% | $0 |
| D | 2026-06-12 20:00 | 2026-06-11 | JANX | Barrett Ronald W | Dir | A - Grant | $0.00 | +5,500 | 11.8K | +88% | $0 |
| 2026-06-04 20:00 | 2026-06-02 | JANX | Doyle Janeen Noel | Chief Corp, Bus. Dev. Ofcr | S - Sale | $14.03 | -4,059 | 75.9K | -5% | -$56.9K | |
| 2026-05-13 20:00 | 2026-05-11 | JANX | Dobek Maria | VP, Accounting | S - Sale | $14.17 | -2,038 | 32.3K | -6% | -$28.9K | |
| D | 2026-02-04 | 2026-02-02 | JANX | Go William | Chief Medical Off | A - Grant | $0.00 | +44.0K | 44.0K | New | $0 |
| D | 2026-01-02 | 2026-01-02 | JANX | DiRaimondo Thomas | CSO | S - Sale | $13.73 | -2,505 | 124.4K | -2% | -$34.4K |
| D | 2026-01-02 | 2026-01-02 | JANX | DiRaimondo Thomas | CSO | A - Grant | $0.00 | +31.4K | 155.8K | +25% | $0 |
| D | 2026-01-02 | 2026-01-02 | JANX | Doyle Janeen Noel | Chief Corp, Bus. Dev. Ofcr | A - Grant | $0.00 | +36.0K | 80.0K | +82% | $0 |
| D | 2026-01-02 | 2026-01-02 | JANX | McIver Zachariah | Chief Medical Off | A - Grant | $0.00 | +29.0K | 52.3K | +125% | $0 |
| D | 2026-01-02 | 2026-01-02 | JANX | McIver Zachariah | Chief Medical Off | S - Sale | $13.73 | -2,714 | 23.3K | -10% | -$37.3K |
| D | 2026-01-02 | 2026-01-02 | JANX | Winter Charles M. | Chief Technical Off | A - Grant | $0.00 | +28.6K | 106.3K | +37% | $0 |
| D | 2026-01-02 | 2026-01-02 | JANX | Winter Charles M. | Chief Technical Off | S - Sale | $13.73 | -2,401 | 77.7K | -3% | -$33.0K |
| D | 2026-01-02 | 2026-01-02 | JANX | Campbell David Alan | Pres, CEO, Dir | A - Grant | $0.00 | +96.6K | 381.6K | +34% | $0 |
| D | 2026-01-02 | 2026-01-02 | JANX | Campbell David Alan | Pres, CEO, Dir | S - Sale | $13.73 | -8,072 | 285.0K | -3% | -$110.8K |
| 2026-01-02 | 2026-01-02 | JANX | Meyer Andrew Hollman | Chief Business Off | S - Sale | $13.73 | -1,879 | 83.1K | -2% | -$25.8K | |
| D | 2026-01-02 | 2026-01-02 | JANX | Dobek Maria | VP, Accounting | A - Grant | $0.00 | +18.9K | 34.3K | +123% | $0 |
| D | 2026-01-02 | 2026-01-02 | JANX | Dobek Maria | VP, Accounting | S - Sale | $13.73 | -1,462 | 15.4K | -9% | -$20.1K |
| DM | 2025-12-03 | 2025-12-01 | JANX | Meyer Andrew Hollman | Chief Business Off | S - Sale+OE | $32.98 | -3,333 | 85.6K | -4% | -$109.9K |
| D | 2025-12-03 | 2025-12-01 | JANX | Meyer Andrew Hollman | Chief Business Off | M - OptEx | $10.59 | +3,333 | 88.3K | +4% | +$35.3K |
| D | 2025-11-14 | 2025-11-14 | JANX | Meyer Andrew Hollman | Chief Business Off | S - Sale+OE | $30.00 | -3,333 | 85.0K | -4% | -$100.0K |
| D | 2025-11-14 | 2025-11-14 | JANX | Meyer Andrew Hollman | Chief Business Off | M - OptEx | $10.59 | +3,333 | 88.3K | +4% | +$35.3K |
| D | 2025-10-30 | 2025-10-28 | JANX | Meyer Andrew Hollman | Chief Business Off | S - Sale+OE | $30.06 | -16.7K | 82.1K | -17% | -$500.9K |
| DM | 2025-10-30 | 2025-10-28 | JANX | Meyer Andrew Hollman | Chief Business Off | M - OptEx | $6.76 | +16.7K | 98.8K | +20% | +$112.7K |
| D | 2025-06-13 | 2025-06-11 | JANX | CAPPS VICKIE L | Dir | A - Grant | $0.00 | +3,750 | 74.1K | +5% | $0 |
| D | 2025-06-13 | 2025-06-11 | JANX | McNulty Alana B. | Dir | A - Grant | $0.00 | +3,750 | 6,250 | +150% | $0 |
| D | 2025-06-13 | 2025-06-11 | JANX | Barrett Ronald W | Dir | A - Grant | $0.00 | +3,750 | 6,250 | +150% | $0 |
| D | 2025-06-13 | 2025-06-11 | JANX | Hernday Natasha | Dir | A - Grant | $0.00 | +3,750 | 8,731 | +75% | $0 |
| D | 2025-06-13 | 2025-06-11 | JANX | Gujrathi Sheila | Dir | A - Grant | $0.00 | +3,750 | 118.9K | +3% | $0 |
| D | 2025-06-13 | 2025-06-11 | JANX | Simson Jake | Dir | A - Grant | $0.00 | +3,750 | 6,250 | +150% | $0 |
| D | 2025-06-13 | 2025-06-11 | JANX | Kung Winston | Dir | A - Grant | $0.00 | +3,750 | 6,250 | +150% | $0 |
| DI | 2025-06-13 | 2025-06-11 | JANX | RA Capital Healthcare Fund LP | Dir, 10% | A - Grant | $0.00 | +3,750 | 6,250 | +150% | $0 |
| D | 2025-06-13 | 2025-06-11 | JANX | DOBMEIER ERIC | Dir | A - Grant | $0.00 | +3,750 | 9,981 | +60% | $0 |
| D | 2025-06-04 | 2025-06-02 | JANX | Doyle Janeen Noel | Chief Corp, Bus. Dev. Ofcr | A - Grant | $0.00 | +44.0K | 44.0K | New | $0 |
| DM | 2025-05-02 | 2025-05-01 | JANX | Meyer Andrew Hollman | Chief Business Off | S - Sale+OE | $32.03 | -3,333 | 82.5K | -4% | -$106.7K |
| D | 2025-05-02 | 2025-05-01 | JANX | Meyer Andrew Hollman | Chief Business Off | M - OptEx | $4.21 | +3,333 | 85.5K | +4% | +$14.0K |
| D | 2025-04-23 | 2025-04-21 | JANX | Meyer Andrew Hollman | Chief Business Off | S - Sale+OE | $30.00 | -3,334 | 82.1K | -4% | -$100.0K |
| D | 2025-04-23 | 2025-04-21 | JANX | Meyer Andrew Hollman | Chief Business Off | M - OptEx | $4.21 | +3,334 | 85.5K | +4% | +$14.0K |
| MI | 2025-03-07 | 2025-03-05+ | JANX | RA Capital Healthcare Fund LP | Dir, 10% | P - Purchase | $30.75 | +824.0K | 9.66M | +9% | +$25.34M |
| D | 2025-03-05 | 2025-03-03 | JANX | Meyer Andrew Hollman | Chief Business Off | M - OptEx | $4.21 | +3,334 | 85.5K | +4% | +$14.0K |
| DM | 2025-03-05 | 2025-03-03 | JANX | Meyer Andrew Hollman | Chief Business Off | S - Sale+OE | $32.14 | -3,334 | 83.0K | -4% | -$107.2K |
| DM | 2025-02-05 | 2025-02-03 | JANX | Meyer Andrew Hollman | Chief Business Off | S - Sale+OE | $42.29 | -3,334 | 83.1K | -4% | -$141.0K |
| D | 2025-02-05 | 2025-02-03 | JANX | Meyer Andrew Hollman | Chief Business Off | M - OptEx | $4.21 | +3,334 | 85.5K | +4% | +$14.0K |
| 2025-01-08 | 2025-01-07 | JANX | Campbell David Alan | Pres, CEO, Dir | S - Sale | $60.00 | -5,000 | 293.1K | -2% | -$300.0K | |
| D | 2025-01-03 | 2025-01-02 | JANX | Winter Charles M. | Chief Technical Off | A - Grant | $0.00 | +23.0K | 77.3K | +42% | $0 |
| D | 2025-01-03 | 2025-01-02 | JANX | DiRaimondo Thomas | CSO | A - Grant | $0.00 | +24.0K | 129.7K | +23% | $0 |
| D | 2025-01-03 | 2025-01-02 | JANX | McIver Zachariah | Chief Medical Off | A - Grant | $0.00 | +26.0K | 26.0K | New | $0 |
| D | 2025-01-03 | 2025-01-02 | JANX | Dobek Maria | VP, Accounting | A - Grant | $0.00 | +14.0K | 14.0K | +1,400,000% | $0 |
| D | 2025-01-03 | 2025-01-02 | JANX | Robinson Byron | Chief Strategy Off | A - Grant | $0.00 | +28.0K | 28.0K | New | $0 |
| D | 2025-01-03 | 2025-01-02 | JANX | Campbell David Alan | Pres, CEO, Dir | A - Grant | $0.00 | +81.0K | 298.1K | +37% | $0 |
| DM | 2025-01-03 | 2025-01-02 | JANX | Meyer Andrew Hollman | Chief Business Off | S - Sale | $54.88 | -13.3K | 82.1K | -14% | -$731.8K |
| D | 2025-01-03 | 2025-01-02 | JANX | Meyer Andrew Hollman | Chief Business Off | A - Grant | $0.00 | +18.0K | 95.5K | +23% | $0 |
| 2024-12-27 | 2024-12-24 | JANX | Campbell David Alan | Pres, CEO, Dir | S - Sale | $56.19 | -25.0K | 217.1K | -10% | -$1.40M | |
| DM | 2024-12-20 | 2024-12-19 | JANX | Meyer Andrew Hollman | Chief Business Off | M - OptEx | $20.24 | +9,881 | 77.5K | +15% | +$200.0K |
| 2024-12-03 | 2024-12-03 | JANX | Campbell David Alan | Pres, CEO, Dir | S - Sale | $67.00 | -15.0K | 242.1K | -6% | -$1.00M | |
| M | 2024-11-27 | 2024-11-25 | JANX | Campbell David Alan | Pres, CEO, Dir | S - Sale | $51.59 | -25.0K | 263.8K | -9% | -$1.29M |
| 2024-11-07 | 2024-11-05 | JANX | Gujrathi Sheila | Dir | J - Other | $0.00 | +4,611 | 115.1K | +4% | $0 | |
| 2024-11-07 | 2024-11-05 | JANX | CAPPS VICKIE L | Dir | J - Other | $0.00 | +2,305 | 70.3K | +3% | $0 | |
| M | 2024-10-30 | 2024-10-28 | JANX | Campbell David Alan | Pres, CEO, Dir | S - Sale | $53.54 | -25.0K | 282.1K | -8% | -$1.34M |
| DM | 2024-10-24 | 2024-09-13 | JANX | Lichter Jay | 10% | M - OptEx | $17.29 | +3,815 | 8,868 | +75% | +$66.0K |
| D | 2024-10-24 | 2024-09-13 | JANX | Lichter Jay | 10% | S - Sale+OE | $46.68 | -3,815 | 7,000 | -35% | -$178.1K |
| I | 2024-10-22 | 2024-10-18 | JANX | Kolchinsky Peter | Dir, 10% | P - Purchase | $44.75 | +1.20M | 9.32M | +15% | +$53.70M |
| DM | 2024-10-18 | 2024-10-16+ | JANX | Avalon BioVentures SPV I, L.P. | 10% | S - Sale+OE | $46.34 | -762.5K | 6,371 | -99% | -$35.34M |
| DM | 2024-10-18 | 2024-10-16+ | JANX | Avalon BioVentures SPV I, L.P. | 10% | M - OptEx | $18.07 | +12.3K | 8,214 | New | +$222.0K |
| DMI | 2024-10-18 | 2024-10-16+ | JANX | Avalon BioVentures SPV I, L.P. | 10% | S - Sale+OE | $46.27 | -910.7K | 509.3K | -64% | -$42.14M |
| DMI | 2024-09-30 | 2024-09-26+ | JANX | Avalon BioVentures I, LP | 10% | S - Sale+OE | $46.96 | -167.3K | 2.88M | -5% | -$7.86M |
| DM | 2024-09-30 | 2024-09-26+ | JANX | Avalon BioVentures I, LP | 10% | S - Sale+OE | $46.95 | -140.5K | 6,926 | -95% | -$6.60M |
| DM | 2024-09-30 | 2024-09-27+ | JANX | Avalon BioVentures I, LP | 10% | M - OptEx | $18.07 | +2,671 | 8,752 | +44% | +$48.3K |
| M | 2024-09-27 | 2024-09-27 | JANX | DiRaimondo Thomas | CSO | S - Sale | $46.35 | -5,000 | 97.9K | -5% | -$231.7K |
| M | 2024-09-27 | 2024-09-27 | JANX | Campbell David Alan | Pres, CEO, Dir | S - Sale | $46.31 | -25.0K | 307.1K | -8% | -$1.16M |
| D | 2024-09-27 | 2024-09-27 | JANX | Meyer Andrew Hollman | Chief Business Off | S - Sale+OE | $45.96 | -50.0K | 67.6K | -43% | -$2.30M |
| D | 2024-09-27 | 2024-09-27 | JANX | Meyer Andrew Hollman | Chief Business Off | M - OptEx | $4.21 | +50.0K | 117.6K | +74% | +$210.5K |
| MI | 2024-09-12 | 2024-09-10+ | JANX | Avalon BioVentures I, LP | 10% | S - Sale | $46.89 | -247.4K | 3.18M | -7% | -$11.60M |
| M | 2024-09-12 | 2024-09-10+ | JANX | Avalon BioVentures I, LP | 10% | S - Sale | $46.89 | -203.7K | 2.96M | -6% | -$9.55M |
| DM | 2024-09-10 | 2024-09-09 | JANX | Avalon BioVentures I, LP | 10% | M - OptEx | $18.03 | +2,099 | 8,077 | +35% | +$37.8K |
| DM | 2024-09-10 | 2024-09-06+ | JANX | Avalon BioVentures I, LP | 10% | S - Sale+OE | $42.01 | -110.5K | 3.16M | -3% | -$4.64M |
| DMI | 2024-09-10 | 2024-09-06 | JANX | Avalon BioVentures I, LP | 10% | S - Sale+OE | $42.00 | -131.6K | 3.23M | -4% | -$5.53M |
| DA | 2024-07-24 | 2024-07-19 | JANX | Hernday Natasha | Dir | A - Grant | $0.00 | +1,231 | 6,231 | +25% | $0 |
| DA | 2024-07-24 | 2024-07-19 | JANX | DOBMEIER ERIC | Dir | A - Grant | $0.00 | +1,231 | 6,231 | +25% | $0 |
| DM | 2024-07-22 | 2024-07-19 | JANX | Hernday Natasha | Dir | A - Grant | $0.00 | +7,500 | 7,500 | New | $0 |
| DM | 2024-07-22 | 2024-07-19 | JANX | DOBMEIER ERIC | Dir | A - Grant | $0.00 | +7,500 | 7,500 | New | $0 |
| DI | 2024-06-28 | 2024-06-26 | JANX | RA CAPITAL MANAGEMENT, L.P. | Dir, 10% | A - Grant | $0.00 | +2,500 | 2,500 | New | $0 |
| D | 2024-06-28 | 2024-06-26 | JANX | Simson Jake | Dir | A - Grant | $0.00 | +2,500 | 2,500 | New | $0 |
| D | 2024-06-28 | 2024-06-26 | JANX | CAPPS VICKIE L | Dir | A - Grant | $0.00 | +2,500 | 68.0K | +4% | $0 |
| D | 2024-06-28 | 2024-06-26 | JANX | Kung Winston | Dir | A - Grant | $0.00 | +2,500 | 2,500 | New | $0 |
| D | 2024-06-28 | 2024-06-26 | JANX | Barrett Ronald W | Dir | A - Grant | $0.00 | +2,500 | 2,500 | New | $0 |
| D | 2024-06-28 | 2024-06-26 | JANX | Gujrathi Sheila | Dir | A - Grant | $0.00 | +2,500 | 110.5K | +2% | $0 |
| D | 2024-06-28 | 2024-06-26 | JANX | Lichter Jay | Dir, 10% | A - Grant | $0.00 | +2,500 | 7,083 | +55% | $0 |
| D | 2024-06-28 | 2024-06-26 | JANX | McNulty Alana B. | Dir | A - Grant | $0.00 | +2,500 | 2,500 | New | $0 |
| MI | 2024-06-05 | 2024-06-03 | JANX | Lichter Jay | Dir, 10% | S - Sale | $54.75 | -1.50M | 3.34M | -31% | -$82.12M |
| MI | 2024-06-05 | 2024-06-03 | JANX | Avalon Ventures XI, L.P. | 10% | S - Sale | $54.75 | -822.7K | 3.34M | -20% | -$45.04M |
| 2024-06-05 | 2024-06-03 | JANX | Avalon Ventures XI, L.P. | 10% | S - Sale | $54.75 | -677.3K | 3.27M | -17% | -$37.08M | |
| MI | 2024-06-05 | 2024-06-03 | JANX | Reardon Tighe | Acting CFO | S - Sale | $54.75 | -822.7K | 633.7K | -56% | -$45.04M |
| 2024-03-04 | 2024-02-29 | JANX | CAPPS VICKIE L | Dir | J - Other | $0.00 | +1,493 | 65.5K | +2% | $0 |
Purchase Sale Sale after option exercise All abbreviations